Though community partners preferred establishing MySafe machines into existing community organizations, they also discussed benefits of housing-based MySafe programs. Conversely, having political and community buy-in, availability of wrap-around services, and collaborative communication from the MySafe team served as facilitators to program implementation. Lastly, technical difficulties were described as barriers to service uptake and delivery. In addition, some participants perceived hydromorphone to be an inadequate substitute to the increasingly toxic street opioid supply. Participants identified a variety of barriers, including the dependence on clinician buy-in, coupled with regulatory and logistical constraints. Thematic analysis of interviews focused on perspectives on safer supply, barriers and facilitators faced during program implementation, and recommendations to inform future scale-up of low-barrier safer supply models across Canada. Semi-structured qualitative interviews were conducted with 17 professional community partners involved in program implementation across four pilot locations in Canada. This study aims to examine professional community partner perspectives on the feasibility, as well as barriers and facilitators to the implementation of the MySafe program. However, the experiences and perspectives of professional community partners on program implementation remain unexplored. While various harm reduction interventions address overdose-related risks, there is growing interest in safer supply programs, including the MySafe Project which utilizes a biometric dispensing machine that provides pharmaceutical opioid alternatives to the toxic drug supply. The adulteration of the illicit drug supply with fentanyl and its analogues is driving the ongoing overdose crisis in North America.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |